Clinical trials
Epigenetics clinical trials
Below are recruiting epigenetics clinical trials, each written for real people, not researchers. We’re tracking 64 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06022328Recruiting
Epigenetic age and prognosis in blood cancers
This study looks at how 'epigenetic age' (a measure of certain changes in your DNA) relates to the way blood cancers called myeloproliferative neoplasms (MPNs) develop and progress. It may help doctors better understand and predict the course of these diseases.
BordeauxAges 18 years+ - NCT07764380Recruiting
Stress during pregnancy and its effects on mothers and babies
This study looks at how stress during pregnancy might affect stress hormones and genes in pregnant women. It aims to understand these effects to better support mothers and babies.
KahramanmaraşAges 18–49 - NCT06888102RecruitingEarly Phase 1
Epigenetic therapy before prostate surgery
This trial tests a short course of 'epigenetic therapy' (drugs that change how genes work) given before prostate removal surgery. The goal is to see if it can improve treatment effects and help shrink or control the tumor.
Los Angeles, CaliforniaAges 18 years+ - NCT05791149Recruiting
Saliva test to help diagnose oral cavity cancer
This study looks for changes in saliva (epigenetic biomarkers) that may help doctors diagnose squamous cell carcinoma in the mouth. You may be asked for saliva samples and usual clinical checks to see whether the test can help with diagnosis, especially before surgery.
Amiens, PicardieAges 18 years+ - NCT06098495Recruiting
Blood test to predict female infertility
This trial looks for a blood test that could help predict infertility in women. If you are between 18 and 43, struggling with infertility or recurrent pregnancy loss, this study may be a fit.
MilanAges 18–43 - NCT07008664Recruiting
DNA test for lung cancer diagnosis
This study is testing a new blood test to help diagnose lung cancer by looking at certain markers in your DNA. Researchers want to see if this test can accurately find lung cancer, which could lead to earlier detection.
Glen Burnie, MarylandAges 18 years+ - NCT07250217Recruiting
Study of AML epigenetic markers in older adults
This trial looks at certain chemical changes in blood cells of two groups of people aged 60 or older: those having heart surgery (control group) and those with a type of blood cancer called acute myeloid leukemia (AML) who will be treated with a drug called azacitidine. The goal is to find markers that could help personalize treatment for AML in seniors.
Mulhouse, AlsaceAges 60 years+ - NCT07436195Recruiting
Epigenetics and cell-free DNA in gestational diabetes study
This study looks at how changes in DNA (called epigenetics) might affect gestational diabetes in pregnancy. It aims to understand these changes using cell-free DNA from the mother and father.
Ulm, Baden-WurttembergAges 18 years+ - NCT06740266Recruiting
Parenting support for mothers and their babies
This study tests if a specially designed parenting program can help mothers and their babies bond better and possibly affect the baby's cells in a positive way. If you are a mother with a baby between 3 and 12 months old, receiving Medicaid, and getting care at WakeMed, you may be able to join.
Raleigh, North CarolinaAges 18 years+ - NCT06690866Recruiting
Emotions and genetics during puberty in girls
This study looks at how emotions and genetics change during puberty in healthy girls. It involves questionnaires, interviews, and possibly an MRI scan to understand these changes.
Tübingen, Baden-WurttembergAges 8–17 - NCT06305091Recruiting
DNA Changes in Veterans Exposed to Burn Pits
This study looks for DNA changes in veterans who were exposed to open burn pits during deployment. It aims to understand health risks from these exposures.
North Little Rock, ArkansasAges 25–70 - NCT02339012Recruiting
Genetic study of healthy and frail aging
This study looks at genes and aging by comparing healthy people, those who are not healthy or frail, and those who are frail. You'll provide blood samples and get MRI scans to help researchers understand aging better.
Baltimore, MarylandAges 20–120 - NCT04986423RecruitingPhase 2
Add ZEN003694 to enzalutamide for resistant prostate cancer
This Phase 2 study tests whether adding ZEN003694 to enzalutamide works better than enzalutamide alone in men whose prostate cancer has spread and is no longer controlled by hormone lowering treatments. It focuses on people who either did not respond well to abiraterone (poor responders) or did respond (responders), then compares outcomes between treatment groups.
Los Angeles, CaliforniaAges 18 years+ - NCT04375657RecruitingPhase 2
Study to restore thymus function and improve insulin control
This Phase 2 study tests a treatment aimed at improving immune system function and reducing insulin problems over 12 months. You may be able to join if you’re between 40 and 80 and don’t have certain diabetes, hormonal, heart, or immune conditions.
Torrance, CaliforniaAges 40–80 - NCT03793062Recruiting
Study genes and wound biology in chronic ulcers
This study looks at how genes and “chemical tags” on cells may contribute to chronic wounds that don’t heal. Your information and possibly samples from the largest wound could help researchers understand why ulcers last so long.
Pittsburgh, PennsylvaniaAges 18–100 - NCT07631624Recruiting
Blood test for lung cancer screening in smokers and former smokers
This study tests whether a simple blood test that detects smoking-related changes in DNA can help identify who should get lung cancer screening. Researchers want to see if this test is better at finding people at risk than current methods.
Antwerp, AntwerpenAges 50 years+ - NCT06372054Recruiting
Predicting health risks for Italian Air Force members
This study aims to develop smart risk models using your body's data (like proteins and genes) along with personal exposure readings. It will help predict health risks for Italian Air Force personnel. You will wear a monitor and give samples, then be followed over time.
MilanAges 26–38 - NCT06761274Recruiting
Aging and inflammation in Hodgkin's lymphoma survivors
This study looks at how biological aging and inflammation affect people with Hodgkin's lymphoma who have finished their first treatment and are in remission. It may help doctors understand long-term health and follow-up needs.
BolognaAges 18 years+ - NCT07417072Recruiting
Brain tumor drug testing using 3D models in children
This study creates 3D models from brain tumor tissue of children aged 3-18 to test how different drugs might work against their specific tumor. The goal is to find more personalized treatments.
Florence, FirenzeAges 3–18 - NCT06838806Recruiting
A blood test to help diagnose risky lung nodules
This trial uses a simple blood test to look at certain genetic markers that may help doctors decide if a lung nodule is cancerous or not. It is designed for people who have a lung nodule that needs further testing like a biopsy or surgery.
TaipeiAges 20 years+ - NCT05963451Recruiting
Testing treatments for long-term low back pain from facet joints
This study focuses on people with long-lasting low back pain that likely comes from the small “facet” joints in the lower spine. It aims to better understand brain, psychological, and biology changes to help optimize treatment for this type of back pain.
Sherbrooke, QuebecAges 18–75 - NCT07738003Recruiting
Perinatal Autism Genetics and Epigenetics Study
This study looks at genetics and other factors that may be linked to autism. Pregnant women in their first or second trimester are invited to join, and their babies will be followed to see how they develop.
Iowa City, IowaAges birth–50 years - NCT07161713Recruiting
Relaxation and stress reduction study for cancer survivors
This study is testing whether relaxation and stress reduction techniques can help your body heal at a cellular level. If you are a cancer survivor who finished treatment at least 6 months ago, you may be able to join.
Stony Brook, New YorkAges 18 years+ - NCT07707778Enrolling by invitationPhase 4
Tirzepatide for Weight and Aging in People with HIV
This trial tests whether a weight-loss medicine called tirzepatide can slow biological aging and improve metabolism in people with HIV who are already on effective treatment. It may help you reduce weight and possibly reverse some signs of aging.
TaipeiAges 18 years+
Hear when a new Epigenetics trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for epigenetics?
- Yes. Clin2 currently lists 64 recruiting epigenetics studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a epigenetics trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a epigenetics trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.